Position in NVS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$613,872
-$868,108 QoQ
Shares Held
3,917
-59.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#801
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Qtron Investments LLC holds $33,905,175 across 13 Drug Manufacturers - General names. NVS ranks #13 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,521 | $9,020,913 | |
| 2 | JNJ |
Johnson & Johnson
|
21,897 | $5,561,181 | |
| 3 | ABBV |
AbbVie Inc.
|
17,841 | $4,489,509 | |
| 4 | MRK |
Merck & Co., Inc.
|
20,088 | $2,581,308 | |
| 5 | AMGN |
Amgen Inc
|
6,469 | $2,342,554 | |
| 6 | AZN |
Astrazeneca PLC
|
11,190 | $2,121,847 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
29,328 | $1,689,879 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
12,413 | $1,568,258 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $613,872 | 3,917 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,481,980 | 9,702 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,336,925 | 9,697 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,483,608 | 11,569 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,422,956 | 11,759 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,310,893 | 11,759 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,035,864 | 10,645 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,332,506 | 11,585 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,140,080 | 10,709 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,223,054 | 12,644 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,186,902 | 11,755 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,197,364 | 11,755 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,186,197 | 11,755 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $487,692 | 5,301 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $480,906 | 5,301 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $335,356 | 4,412 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $534,567 | 6,324 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $368,111 | 4,195 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $366,936 | 4,195 | Shares | Sole | 2022-02-16 | |
| 2021-09-30 | $519,548 | 6,353 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $392,514 | 4,302 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $725,554 | 8,488 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $520,026 | 5,507 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $464,279 | 5,339 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $521,681 | 5,973 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $658,610 | 7,988 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||